inflammation

Immune responses to the gut microbiota can be used as biomarkers of clinical course in IBD or as targets for the treatment or prevention of the condition.

A two-pronged treatment strategy — consisting of an engineered peptide and an FDA-approved drug —  could help to reduce gut inflammation.

Diets high in fat and sugar cause colon inflammation by disrupting the gut microbiota. A study published in Science Translational Medicine claims.

Cells in the gut sense commensal microbes through receptors that trigger the production of inflammatory molecules and the activation of the immune system.